Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2
Open Access
- 1 January 2008
- journal article
- research article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 40 (3) , 345-353
Abstract
Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.Keywords
This publication has 37 references indexed in Scilit:
- A novel way of therapeutic angiogenesis using an adeno-associated virus-mediated angiogenin gene transferExperimental & Molecular Medicine, 2007
- Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with NeuroblastomaMolecular Therapy, 2007
- Low-dose radiation response of the p21(WAF1/CIP1) gene promoter transduced by adeno-associated virus vectorExperimental & Molecular Medicine, 2006
- Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicabilityJournal of Controlled Release, 2006
- Regulation of tyrosine hydroxylase gene expression by retinoic acid receptorJournal of Neurochemistry, 2006
- Adeno-associated virus vectors: potential applications for cancer gene therapyCancer Gene Therapy, 2005
- Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesisOncogene, 2004
- Tumor-specific gene expression using the survivin promoter is further increased by hypoxiaGene Therapy, 2004
- Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectorsCancer Gene Therapy, 2001
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994